Growth Metrics

Standard Biotools (LAB) EBIT Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -20.56%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 11.83%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -11.06%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 19.54%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 20.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 74.18%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 90.95%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -18.12%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 46.60%
10 Standard Biotools 448.37 Mn -6.80 Mn 11.31 Mn 53.67%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 53.67%
Dec 31, 2025 -129.90%
Sep 30, 2025 -23.37%
Jun 30, 2025 15.08%
Mar 31, 2025 55.19%
Dec 31, 2024 107.97%
Sep 30, 2024 -26.11%
Jun 30, 2024 -73.43%
Mar 31, 2024 -262.70%
Dec 31, 2023 287.72%
Sep 30, 2023 27.06%
Jun 30, 2023 54.75%
Mar 31, 2023 39.67%
Sep 30, 2022 -48.01%
Jun 30, 2022 -123.32%
Mar 31, 2022 -42.36%
Sep 30, 2021 -258.93%
Jun 30, 2021 -25.81%
Mar 31, 2021 -29.30%
Dec 31, 2020 -84.12%
Sep 30, 2020 60.45%
Jun 30, 2020 6.22%
Mar 31, 2020 -5.18%
Dec 31, 2019 17.42%
Sep 30, 2019 -18.82%
Jun 30, 2019 -14.48%
Mar 31, 2019 -12.45%
Dec 31, 2018 -27.28%
Sep 30, 2018 25.47%
Jun 30, 2018 22.45%
Mar 31, 2018 27.96%
Dec 31, 2017 50.64%
Sep 30, 2017 15.59%
Jun 30, 2017 9.12%
Mar 31, 2017 7.06%
Dec 31, 2016 -29.24%
Sep 30, 2016 -136.87%
Jun 30, 2016 -23.76%
Mar 31, 2016 -34.77%
Dec 31, 2015 -39.25%
Sep 30, 2015 40.19%
Jun 30, 2015 -18.44%
Mar 31, 2015 15.55%
Dec 31, 2014 -111.74%
Sep 30, 2014 -163.47%
Jun 30, 2014 -210.20%
Mar 31, 2014 -227.20%
Dec 31, 2013 -32.95%
Sep 30, 2013 -26.68%
Jun 30, 2013 9.03%
Mar 31, 2013 19.35%
Dec 31, 2012 -17.25%
Sep 30, 2012 3.60%
Jun 30, 2012 34.08%
Mar 31, 2012 -28.80%
Dec 31, 2011 -48.21%
Sep 30, 2011 -30.85%
Jun 30, 2011 -57.45%